These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 30243944

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The impact of phospholipids with high transition temperature to enhance redox-sensitive liposomal doxorubicin efficacy in colon carcinoma model.
    Mirhadi E, Askarizadeh A, Farhoudi L, Mashreghi M, Behboodifar S, Alavizadeh SH, Arabi L, Jaafari MR.
    Chem Phys Lipids; 2024 Jul; 261():105396. PubMed ID: 38621603
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K, Sundaresan A, Cheow WS.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [Abstract] [Full Text] [Related]

  • 5. Investigation of Hexadecylphosphocholine (miltefosine) usage in Pegylated liposomal doxorubicin as a synergistic ingredient: In vitro and in vivo evaluation in mice bearing C26 colon carcinoma and B16F0 melanoma.
    Teymouri M, Farzaneh H, Badiee A, Golmohammadzadeh S, Sadri K, Jaafari MR.
    Eur J Pharm Sci; 2015 Dec 01; 80():66-73. PubMed ID: 26299343
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.
    Krishna R, Mayer LD.
    Cancer Res; 1997 Dec 01; 57(23):5246-53. PubMed ID: 9393743
    [Abstract] [Full Text] [Related]

  • 10. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M, Badiee A, Golmohammadzadeh S, Sadri K, Akhtari J, Mellat M, Nikpoor AR, Jaafari MR.
    Int J Pharm; 2016 Sep 10; 511(1):236-244. PubMed ID: 27363937
    [Abstract] [Full Text] [Related]

  • 11. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA, Abnous K, Badiee A, Jaafari MR.
    Colloids Surf B Biointerfaces; 2016 Mar 01; 139():228-36. PubMed ID: 26722819
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors.
    Lim HJ, Masin D, McIntosh NL, Madden TD, Bally MB.
    J Pharmacol Exp Ther; 2000 Jan 01; 292(1):337-45. PubMed ID: 10604968
    [Abstract] [Full Text] [Related]

  • 14. Sequential administration of PEG-Span 80 niosome enhances anti-tumor effect of doxorubicin-containing PEG liposome.
    Minamisakamoto T, Nishiguchi S, Hashimoto K, Ogawara KI, Maruyama M, Higaki K.
    Eur J Pharm Biopharm; 2021 Dec 01; 169():20-28. PubMed ID: 34461216
    [Abstract] [Full Text] [Related]

  • 15. Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics.
    Gkionis L, Aojula H, Harris LK, Tirella A.
    Int J Pharm; 2021 Jul 15; 604():120711. PubMed ID: 34015381
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
    Korani M, Nikoofal-Sahlabadi S, Nikpoor AR, Ghaffari S, Attar H, Mashreghi M, Jaafari MR.
    Anticancer Agents Med Chem; 2020 Jul 15; 20(6):700-708. PubMed ID: 31893998
    [Abstract] [Full Text] [Related]

  • 19. Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery.
    Li Y, Wang M, Huang BW, Ping Y, You J, Gao JQ.
    Int J Nanomedicine; 2017 Jul 15; 12():8557-8572. PubMed ID: 29238192
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.